 < .002). The rate of any
stroke or death within 30 days after treatment in the
CAS group was more than twice the rate recorded for
the CEA group (7.4% vs 3.4%; P< .0004). In addition, the
composite endpoint of stroke, death, and MI signiï¬cantly
favored CEA (5.2%) vs CAS (8.5%; P < .006